Anna E. Wentz, PhD

Senior Researcher
Carelon Research
Wilmington, Delaware, United States

Disclosure information not submitted.

Presentation(s):

• 1D-02 - Risk of Incident Supraventricular Tachycardia Following Exposure to Recombinant Zoster Vaccine in Adults ≥50 Years of Age in the United States

  Sunday, August 24, 2025
  10:45 AM - 11:00 AM ET

• 1D-05 - Rapid Surveillance Study to Evaluate Safety of Respiratory Syncytial Virus (RSV) Vaccine (ABRYSVO™) Exposure During Pregnancy in the United States

  Sunday, August 24, 2025
  11:30 AM - 11:45 AM ET